KEEN Women's Rose Sandal - Gargoyle/Raven

KEEN Women's Rose Sandal - Gargoyle/Raven

Marsoni

M251S

$120.00

Get it in 3 business days with 1 day shipping. Friday, May 29

KEEN Women's Rose Sandal - Gargoyle/RavenA women's sandal built for adventure. Check out the Rose Sandal from KEEN. The KEEN Rose Sandal combines style and performance in a sandal that is ready for any adventure. The adjustable hook and loop closure ensures a secure fit, and the multi directional lug pattern provides maximum traction on all surfaces. Contoured FitFollows foot's contours for a more secure fit Adjustable hook and loop straps for a secure fit Foam midsole for lightweight

Easy Shipping

Quick Dispatch:

Your KEEN Women's Rose Sandal - Gargoyle/Raven orders ship within 1-2 business days.

Delivery Options:

Standard: 3-7 business days
Fast: 2-3 business days
Express: 1-2 business days

Order Tracking:

You'll receive a tracking link by email once your KEEN Women's Rose Sandal - Gargoyle/Raven ships.

Need Help?
Questions about KEEN Women's Rose Sandal - Gargoyle/Raven, sizing, or delivery? We're just an email away.

Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for KEEN Women's Rose Sandal - Gargoyle/Raven in your area.

Get Shipping Estimates

Country Zip/Postal Code

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy

I bought these to try out, and I was shocked to find they worked out better than my silk pillowcases. I have atopic dermatitis, and I need a pillowcase that doesn't irritate my skin. I also am having hot flashes and need something cool on my face. These pillowcases are perfect for both my conditions. I plan to buy more in different colors. My sons and husband also like it since they are always hot.

WAS THIS REVIEW HELPFUL?YesReportShare

Reviewed in the United States on May 30, 2026